Glenmark Pharmaceuticals Limited (NSE:GLENMARK)

Glenmark Pharmaceuticals Revenue

Glenmark Pharmaceuticals had revenue of 42.47B INR in the quarter ending September 30, 2026, a decrease of -29.76%. This brings the company's total for the last twelve months to 159.97B. In the fiscal year ending March 31, 2026, Glenmark Pharmaceuticals had annual revenue of 170.43B with 27.53% growth. That makes Glenmark Pharmaceuticals the 5,548th largest company in the world by revenue and 193rd in India.

• Revenue (ttm): 159.97B
• Revenue Growth: +27.53%
• P/S Ratio: 4.69
• Revenue / Employee: 9.44M
• Employees: 16,946
• Market Cap: 750.65B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• North America 71.39B 42.0%
• India 37.24B 21.9%
• Europe 31.79B 18.7%
• Latin America and Rest of The World 29.40B 17.3%

Fiscal year ended Mar 31, 2026 See the full Glenmark Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	170.43B	36.79B	27.53%
Mar 31, 2025	133.63B	7.18B	5.68%
Mar 31, 2024	126.45B	9.90B	8.49%
Mar 31, 2023	116.56B	-6.49B	-5.28%
Mar 31, 2022	123.05B	13.61B	12.44%

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error